Beam Therapeutics Inc. Common Stock (BEAM) Sentiment
30-day SentiSense Score 6.52 · Bullish · ▼ cooling · as of 2026-09-23
BEAM sentiment is slightly bullish (30-day SentiSense Score 7) and cooling from a month ago; today's read has cooled to 4, below its 30-day average. Attention averages ~5 mentions/day (2 today).
- Sentiment (30-day)
- Slightly Bullish
- SentiSense Score (30-day avg)
- 6.52
- Today's read
- 4.01 (Neutral)
- Mentions / day (30-day avg)
- 5 (2 today)
Where the conversation is happening
- News
- Bullish · 57% of mentions
- X
- Bullish · 26% of mentions
- Neutral · 17% of mentions
Related tickers
What's driving it
- Prime Medicine Wins Arbitration Over AATD Therapy PM647 (+0.6)
- FDA Clears Gene Therapy Trial for Phenylketonuria (PKU) (+0.78)
- Beam Therapeutics Advances Phase 1/2 Trial for AAT Deficiency with Gene-Editing Therapy (+1)
Live SentiSense Score, sentiment history, and per-source breakdown for Beam Therapeutics Inc. Common Stock on SentiSense.
See how BEAM's sector compares in the market sentiment heatmap